SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Category: Promising drugs and vaccines and Treatment

Preprint: Preprint

Tags: ACE2, antiviral, laboratory trials, scheme, serine protease, TMPRSS2, treatment, and viral entry

Source: ScienceDirect

Source link: https://www.sciencedirect.com/science/article/pii/S0092867420302294

Date of publication: 03/05/2020

Added: 03/06/2020 07:59

Download PDF

2020.03.05-Cell-SARS-CoV-2-Cell-Entry-Depends-on-ACE2-and-TMPRSS2-and-Is-Blocked-by-a-Clinically-Proven-Protease-Inhibitor